Avenue, Myovant top healthcare gainers; Clene, Apellis lead losers' pack

Oct. 03, 2022 10:02 AM ETCALA, AIMD, MYOV, ATXI, APLS, INM, CLNN, PYXS, LUCY, SHPHBy: Ravikash, SA News Editor

stock market

hxdbzxy/iStock via Getty Images

  • Gainers: Avenue Therapeutics (ATXI) +48%. Myovant Sciences (MYOV+38%. Calithera Biosciences (CALA+18%. Innovative Eyewear (LUCY) +15%. Pyxis Oncology (PYXS+14%.
  • Losers: Clene (CLNN-25%. Apellis Pharmaceuticals (APLS-12%. Ainos (AIMD) -11%. Shuttle Pharmaceuticals (SHPH) -10%. InMed Pharmaceuticals (INM) -6%.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.